Core Scientific’s stock rose modestly by 0.8% post-earnings, reflecting investor appreciation for continued execution and capital raises but tempered by no clear breakout in guidance or margins.

• Revenue-generating capacity reached approximately 245 megawatts, with an additional 200 megawatts expected shortly.
• Closed a $3.3 billion capital raise tied to CoreWeave contracts to fund future growth and equipment purchases.
• Five sites are fully leased and financed by tenants, underscoring capital efficiency but raising dependency on tenant-backed contracts.
• Acceleration of development projects is underway at multiple sites, including a pivot at Pecos from Bitcoin mining to high-density colocation.
• Management highlights increased customer engagement, especially among hyperscalers, chip makers, and AI labs, albeit noting that emerging customer segments require additional credit support.